The Israel's Ministry of Health (MOH) has granted approval to Medgenics to initiate two Phase I/II clinical trials of a subcutaneous autologous tissue implant, INFRADURE, in patients with hepatitis C. The objective of the trials is to ...
Tags: MOH, clinical trial, medical research
Medgenics has filed an investigational new drug (IND) application with the FDA to initiate a Phase IIb multi-center, 100-patient clinical trial. The trial is designed to evaluate the safety and efficacy of sustained erythropoietin (EPO) ...
Medgenics Medical Israel (MMI) has received government grant worth NIS8.1m (approximately $2.2m) from the Office of the Chief Scientist (OCS) at the Ministry of Industry, Trade and Labor of Israel. The grant will support R&D expenses for ...
Tags: government grant, Biopump platform technology, hepatitis